Late Effects in Children Treated With Intensive Multimodal Therapy for High-Risk Neuroblastoma: High Incidence of Endocrine and Growth Problems

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2013.218
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Feasibility of Administering High-Dose131I-Mibg Therapy to Children With High-Risk Neuroblastoma Without Lead-Lined Rooms

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2016English

Dinutuximab Combination Therapy Becomes First Approval for High-Risk Neuroblastoma

Journal of Community and Supportive Oncology
OncologyHematology
2015English

Spotlight on Dinutuximab in the Treatment of High-Risk Neuroblastoma: Development and Place in Therapy

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2018English

Possible Risk Factors Associated With Relapse in Patients Treated With Neoadjuvant Chemohormonal Therapy for High Risk Prostate Cancer

The Open Prostate Cancer Journal
2011English

Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue

Frontiers in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Telomere Maintenance Is Pivotal for High-Risk Neuroblastoma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2016English

Maintenance DFMO Increases Survival in High Risk Neuroblastoma

Scientific Reports
Multidisciplinary
2018English

Outcomes After Radiation Therapy for Very Young Children With High-Risk Medulloblastoma or Supratentorial Primitive Neuroectodermal Tumor Treated on COG ACNS0334

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

High Incidence of Hox11L2 Expression in Children With T-All

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy